top of page

ABCI2 Background

The National Academy of Medicine (formerly the Institute of Medicine) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20–21, 2015, to explore policy changes that might increase private sector investment in research and development (R&D) innovation that fills unmet medical needs for central nervous system (CNS) disorders. Workshop participants strategized about how to incentivize companies to fortify their CNS drug development programs, shrinking obstacles that currently deter ventures. Representatives from academia, government agencies, patient groups, and industry gathered to share information and viewpoints, and to brainstorm about budget-neutral policy changes that could help widen the pipeline toward drugs that address unmet needs of patients living with CNS disorders.

  • View the Workshop Agenda here.

  • View the Workshop Summary, published July 6, 2015, here.

  • View Excerpts from the Workshop Summary here.

  • The ABC has made a considerable effort to educate our community on the need to continue these conversations, and through the American Brain Coalition Innovation Initiative (ABCI2), has convened experts to discuss the challenges and identify potential solutions.

  • The ABCI2 Task Force, the body designed to develop the action plan for carrying out the ABCI2’s mission outlined a plan for how to best move the Initiative forward.  

  • View the ABCI2 Process Summary here.

  • Listen to an ABCI2 overview here.

hieshetter_web.jpg

“We hope to build on the community momentum we’ve created as a result of our focus on generating scientific breakthroughs. After all, scientific advancements have little value if not available to the people that need them.”

Janet Hieshetter, ABC Past Chair

bottom of page